Bob Bradway

Person

Heard in 2 episodes across 1 show since Nov 2025

Robert A. Bradway is an American business executive who served as chairman and chief executive officer of Amgen, a biotechnology company.

Episodes

across 1 show

First heard

Nov 2025

Guest appearances

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data

Email alert

One email a week at most, with the new episodes that mention Bob Bradway. Free, no account needed, unsubscribe in one click.

9 statements

on Amgen MaritidePositiveJan 14, 2026· Mad Money w/ Jim Cramer
Amgen’s Maritide may offer multiple ways to maintain weight loss.
“we think there are a bunch of ways to win for patients when it comes to Maritide and maintaining weight loss”
Listen at 17:29
Open the episode · Mad Money w/ Jim Cramer 1/13/26
on Amgen MaritidePositiveJan 14, 2026· Mad Money w/ Jim Cramer
Amgen’s Maritide can induce substantial weight loss during its first year.
“we know that we can induce a very impressive weight loss over the first 52 weeks”
Listen at 18:02
Open the episode · Mad Money w/ Jim Cramer 1/13/26
on RepathaPositiveJan 14, 2026· Mad Money w/ Jim Cramer
Repatha reduced heart-attack risk by 36% in a study.
“we were able to further reduce the risk of heart attack. In fact, by... 36% for people in this study.”
Listen at 20:31
Open the episode · Mad Money w/ Jim Cramer 1/13/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

2 episodes featuring Bob Bradway, newest first